GREENLEAF TRUST - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,130 filers reported holding BAXTER INTL INC in Q1 2022. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
GREENLEAF TRUST ownership history of BAXTER INTL INC
ValueSharesWeighting
Q3 2023$515,113
-31.3%
13,649
-17.1%
0.01%
-25.0%
Q2 2023$750,009
+21.3%
16,462
+8.0%
0.01%
+14.3%
Q1 2023$618,256
+96653.7%
15,243
+21.6%
0.01%
-12.5%
Q4 2022$639
-99.9%
12,540
-1.7%
0.01%
-20.0%
Q3 2022$687,000
-10.2%
12,754
+7.1%
0.01%
-16.7%
Q2 2022$765,000
-17.0%
11,909
+0.1%
0.01%
+9.1%
Q1 2022$922,000
-8.6%
11,893
+1.2%
0.01%
-8.3%
Q4 2021$1,009,000
+13.4%
11,753
+6.2%
0.01%
+9.1%
Q3 2021$890,000
-12.0%
11,062
-11.9%
0.01%
-15.4%
Q2 2021$1,011,000
-8.3%
12,560
-3.9%
0.01%
-13.3%
Q1 2021$1,102,000
+4.1%
13,065
-1.0%
0.02%
+7.1%
Q4 2020$1,059,000
+9.7%
13,197
+9.9%
0.01%
-6.7%
Q3 2020$965,000
-16.9%
12,005
-11.0%
0.02%
-25.0%
Q2 2020$1,161,000
+19.7%
13,486
+12.8%
0.02%
+5.3%
Q1 2020$970,000
+4.0%
11,953
+7.2%
0.02%
+26.7%
Q4 2019$933,000
-7.0%
11,152
-2.7%
0.02%
-6.2%
Q3 2019$1,003,000
+14.1%
11,465
+6.8%
0.02%
+14.3%
Q2 2019$879,000
+3.5%
10,738
+2.8%
0.01%0.0%
Q1 2019$849,000
+32.9%
10,445
+7.6%
0.01%
+7.7%
Q4 2018$639,000
-0.3%
9,711
+16.7%
0.01%
+8.3%
Q3 2018$641,000
-0.6%
8,321
-4.8%
0.01%0.0%
Q2 2018$645,000
+41.4%
8,737
+24.7%
0.01%
+33.3%
Q1 2018$456,000
+5.3%
7,008
+4.6%
0.01%0.0%
Q4 2017$433,000
+8.2%
6,701
+5.0%
0.01%0.0%
Q3 2017$400,000
+21.6%
6,382
+17.3%
0.01%
+12.5%
Q2 2017$329,000
+15.0%
5,441
-1.4%
0.01%
+14.3%
Q1 2017$286,000
+13.0%
5,516
-3.2%
0.01%0.0%
Q4 2016$253,0005,6980.01%
Other shareholders
BAXTER INTL INC shareholders Q1 2022
NameSharesValueWeighting ↓
JONES ROAD CAPITAL MANAGEMENT, L.P. 200,000$7,548,0006.60%
BOONE CAPITAL MANAGEMENT LLC 469,405$17,715,3455.59%
Soditic Asset Management LLP 186,920$7,054,3615.43%
JONES ROAD CAPITAL MANAGEMENT, L.P. 131,000$4,943,9404.32%
Camber Capital Management LP 3,000,000$113,2203.73%
Carmignac Gestion 4,848,773$182,991,7183.36%
SHAPIRO CAPITAL MANAGEMENT LLC 3,028,799$114,306,8743.33%
Hillman Capital Management, Inc. 219,248$8,274,4203.19%
Cincinnati Specialty Underwriters Insurance CO 201,500$7,604,6102.90%
Callodine Capital Management, LP 265,000$10,001,1002.79%
View complete list of BAXTER INTL INC shareholders